Vasodilation: Clinical Trials

4 trials for Vasodilation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 recruiting. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 2, Active not recruiting 1, Recruiting 1

Follow Vasodilation: new trials by email Literature Review of Vasodilation trials Research Report on Vasodilation

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
Phenylephrine Hydrochloride, Isoproterenol Hydrochloride, Norepinephrine Bitartrate - Vasoconstriction, Vasodilation
Phase 4RecruitingUniversity of Alberta302023-10-312026-01-08
Impact of Estradiol on Endothelial Function in Peri-Menopausal Women
Estradiol (mylan or vivelle dot patch), Placebo - Perimenopause, Vasodilation
Phase 4Active not recruitingUniversity of Delaware802020-10-012026-04-29
The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure
Neprilysin, Enalapril - Heart Failure, Exercise Tolerance
Phase 4CompletedUniversity of Sao Paulo General Hospital522017-06-142020-10-22
Renal and Systemic Vascular Resistance in Chronic Kidney Disease (CKD)
Beta-blocker, ACE-inhibitor, Calcium Channel Blockers, ACE-Inhibitor - Chronic Kidney Insufficiency, Hypertension
Phase 4CompletedUniversity of Aarhus832011-02-012014-02-27

Narrower conditions

Aneurysm (4)  ·  Heart Failure (1)  ·  Hypertension (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Cardiovascular Diseases (4)  ·  Vascular Diseases (4)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Heart Diseases (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Angiotensin-Converting Enzyme Inhibitors (2)  ·  Adrenergic beta-Antagonists (1)  ·  Calcium Channel Blockers (1)  ·  Enalapril (1)  ·  Estradiol (1)  ·  Isoproterenol (1)  ·  Neprilysin (1)  ·  Norepinephrine (1)  ·  Phentolamine (1)  ·  Phenylephrine (1)  ·  Propranolol (1)  ·  sacubitril and valsartan sodium hydrate drug combination (1)

Sponsors

University of Aarhus (1)  ·  University of Alberta (1)  ·  University of Delaware (1)  ·  University of Sao Paulo General Hospital (1)

Countries

Brazil (1)  ·  Canada (1)  ·  Denmark (1)  ·  United States (1)

Top investigators

Antonio P Barretto, PhD (1)  ·  Craig Steinback, PhD (1)  ·  Niels Henrik Buus, DrMedSc (1)  ·  Sean van Diepen, MD, MSc (1)

Results publications

PMID 33992607, PMID 39485702

NIH funding

R01HL146558 (1)